These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 15833830

  • 21. Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylate.
    Ray A, Okouneva T, Manna T, Miller HP, Schmid S, Arthaud L, Luduena R, Jordan MA, Wilson L.
    Cancer Res; 2007 Apr 15; 67(8):3767-76. PubMed ID: 17440090
    [Abstract] [Full Text] [Related]

  • 22. Microtubule alterations and resistance to tubulin-binding agents (review).
    Drukman S, Kavallaris M.
    Int J Oncol; 2002 Sep 15; 21(3):621-8. PubMed ID: 12168109
    [Abstract] [Full Text] [Related]

  • 23. 15-Deoxi-Delta(12,14)-prostaglandin J2 is a tubulin-binding agent that destabilizes microtubules and induces mitotic arrest.
    Cocca C, Dorado J, Calvo E, López JA, Santos A, Perez-Castillo A.
    Biochem Pharmacol; 2009 Nov 15; 78(10):1330-9. PubMed ID: 19576185
    [Abstract] [Full Text] [Related]

  • 24. Tubulin-perturbing naphthoquinone spiroketals.
    Balachandran R, Hopkins TD, Thomas CA, Wipf P, Day BW.
    Chem Biol Drug Des; 2008 Feb 15; 71(2):117-24. PubMed ID: 18194192
    [Abstract] [Full Text] [Related]

  • 25. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC, Buey RM, Gussio R, Marcus AI, Vanderwal CD, Sorensen EJ, Díaz JF, Giannakakou P, Hamel E.
    Biochemistry; 2005 Aug 30; 44(34):11525-38. PubMed ID: 16114889
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and cytotoxicity of novel imidazo[4,5-d]azepine compounds derived from marine natural product ceratamine A.
    Pan X, Tao L, Ji M, Chen X, Liu Z.
    Bioorg Med Chem Lett; 2018 Mar 01; 28(5):866-868. PubMed ID: 29433924
    [Abstract] [Full Text] [Related]

  • 27. 7-Diethylamino-3(2'-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells.
    Kim SN, Kim NH, Park YS, Kim H, Lee S, Wang Q, Kim YK.
    Biochem Pharmacol; 2009 Jun 15; 77(12):1773-9. PubMed ID: 19428332
    [Abstract] [Full Text] [Related]

  • 28. Kinetic stabilization of microtubule dynamic instability by benomyl increases the nuclear transport of p53.
    Rathinasamy K, Panda D.
    Biochem Pharmacol; 2008 Dec 15; 76(12):1669-80. PubMed ID: 18823952
    [Abstract] [Full Text] [Related]

  • 29. Securinine induces mitotic block in cancer cells by binding to tubulin and inhibiting microtubule assembly: A possible mechanistic basis for its anticancer activity.
    Ashraf SM, Mahanty S, Rathinasamy K.
    Life Sci; 2021 Dec 15; 287():120105. PubMed ID: 34756929
    [Abstract] [Full Text] [Related]

  • 30. [Effects of beta-sitosterol on microtubular systems in cervical cancer cells].
    Wang L, Yang YJ, Chen SH, Ge XR, Xu CJ, Gui SQ.
    Zhonghua Yi Xue Za Zhi; 2006 Oct 24; 86(39):2771-5. PubMed ID: 17199997
    [Abstract] [Full Text] [Related]

  • 31. [Antimicrotubule agents can activate different apoptotic pathways].
    Kisurina-Evgen'eva OP, Briantseva SA, Stil' AA, Onishchenko GE.
    Biofizika; 2006 Oct 24; 51(5):875-9. PubMed ID: 17131827
    [Abstract] [Full Text] [Related]

  • 32. Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity.
    Acharya BR, Choudhury D, Das A, Chakrabarti G.
    Biochemistry; 2009 Jul 28; 48(29):6963-74. PubMed ID: 19527023
    [Abstract] [Full Text] [Related]

  • 33. Microtubule assembly dynamics: an attractive target for anticancer drugs.
    Singh P, Rathinasamy K, Mohan R, Panda D.
    IUBMB Life; 2008 Jun 28; 60(6):368-75. PubMed ID: 18384115
    [Abstract] [Full Text] [Related]

  • 34. Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding.
    Srivastava P, Panda D.
    FEBS J; 2007 Sep 28; 274(18):4788-801. PubMed ID: 17697112
    [Abstract] [Full Text] [Related]

  • 35. MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps.
    Kasibhatla S, Baichwal V, Cai SX, Roth B, Skvortsova I, Skvortsov S, Lukas P, English NM, Sirisoma N, Drewe J, Pervin A, Tseng B, Carlson RO, Pleiman CM.
    Cancer Res; 2007 Jun 15; 67(12):5865-71. PubMed ID: 17575155
    [Abstract] [Full Text] [Related]

  • 36. Total synthesis of microtubule-stabilizing agent ceratamine A.
    Feng Q, Tao L, Liu Z.
    J Org Chem; 2013 Dec 20; 78(24):12814-8. PubMed ID: 24304123
    [Abstract] [Full Text] [Related]

  • 37. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo.
    Wong VK, Chiu P, Chung SS, Chow LM, Zhao YZ, Yang BB, Ko BC.
    Clin Cancer Res; 2005 Aug 15; 11(16):6002-11. PubMed ID: 16115945
    [Abstract] [Full Text] [Related]

  • 38. Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines.
    Mulligan JM, Greene LM, Cloonan S, Mc Gee MM, Onnis V, Campiani G, Fattorusso C, Lawler M, Williams DC, Zisterer DM.
    Mol Pharmacol; 2006 Jul 15; 70(1):60-70. PubMed ID: 16571652
    [Abstract] [Full Text] [Related]

  • 39. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T, Wartmann M, Brueggen J, Allegrini PR, Floersheimer A, Maira M, McSheehy PM.
    Cancer Chemother Pharmacol; 2008 Nov 15; 62(6):1045-54. PubMed ID: 18301895
    [Abstract] [Full Text] [Related]

  • 40. Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding.
    Gupta KK, Bharne SS, Rathinasamy K, Naik NR, Panda D.
    FEBS J; 2006 Dec 15; 273(23):5320-32. PubMed ID: 17069615
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.